Future of HIV care at The Alfred takes shape
The legacy of almost three decades of HIV care at Fairfield House is set to live on, with the upcoming opening of the new Fairfield Centre at The Alfred.
Visitor information – Everything you need to know about visiting our sites.
The legacy of almost three decades of HIV care at Fairfield House is set to live on, with the upcoming opening of the new Fairfield Centre at The Alfred.
The Alfred hospital has commenced clinical trials with BrainEye, a ground-breaking smartphone app which can help screen for neurological abnormalities using a 60 second eye movement test.
A world-class melanoma and cancer centre at The Alfred is set to revolutionise care for Victorian patients, and boost research.
Victoria’s first public-funded adult concussion clinic is now open, providing much-needed support for hundreds of people experiencing ongoing concussion symptoms each year.
With the number of older people needing hospital care following falls and other accidents on the rise, trauma specialists and geriatricians at The Alfred are working side-by-side to improve patient outcomes.
The Alfred continues to support the advancement of global emergency care, with a team of talented multidisciplinary staff recently returning from delivering training for their emergency care counterparts in the United Arab Emirates.
When Hawthorn-man Hugh experienced a cardiac arrest at the gym it was a fast-acting loved one, followed by the unique skills of a rapid-response team from The Alfred and Ambulance Victoria, that saw him live another day.
Living amongst the highest rates of melanoma in the world, Australians are being urged to become more familiar with their skin and ‘be all over melanoma’ this Check for Spots Day.
Following a concerning spike in preventable burns injuries since December, burns specialists at The Alfred have joined forced with the CFA to issue an urgent call for action: take care around fire this Australia Day long weekend.
Breakthrough Victoria has invested $12 million to progress Phase 2 clinical trials of a promising peanut allergy treatment, initially developed by Alfred Health and Monash University researchers.